Literature DB >> 11960584

The role of infection in the genesis and complications of atherosclerosis.

Joseph S Alpert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11960584     DOI： 10.1007/s11886-002-0045-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  12 in total

Review 1.  Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?

Authors:  A J Camm; K M Fox
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

2.  Secondary prevention antibiotic treatment trials for coronary artery disease.

Authors:  J T Grayston
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

3.  Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.

Authors:  J B Muhlestein; J L Anderson; J F Carlquist; K Salunkhe; B D Horne; R R Pearson; T J Bunch; A Allen; S Trehan; C Nielson
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 4.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.

Authors:  P Libby; D Egan; S Skarlatos
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

Review 5.  The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.

Authors:  A Ismail; H Khosravi; H Olson
Journal:  Heart Dis       Date:  1999 Sep-Oct

6.  Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.

Authors:  M Mayr; S Kiechl; J Willeit; G Wick; Q Xu
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Prospective study of pathogen burden and risk of myocardial infarction or death.

Authors:  J Zhu; F J Nieto; B D Horne; J L Anderson; J B Muhlestein; S E Epstein
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

8.  Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease.

Authors:  Y K Wong; K D Dawkins; M E Ward
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

Review 9.  Infections and atherosclerosis.

Authors:  M Leinonen; P Saikku
Journal:  Scand Cardiovasc J       Date:  2000       Impact factor: 1.589

10.  Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; R Kundsin; J Shih
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391
View more
  1 in total

Review 1.  Immunoactivation at the crossroads of human disease.

Authors:  Leonid Margolis
Journal:  Am J Med       Date:  2015-01-28       Impact factor: 4.965
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.